{"id": "1357150633170595840", "creation": 1612404900.0, "user_id": "1211892441529241601", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 1, "reply_count": 0, "like_count": 2, "quote_count": 2}}, "text": "A #Shenzhen-based #drugmaker on Feb. 2 began trial production of a #COVID19 #vaccine from @AstraZeneca. Shenzhen Kangtai Biological Products Co. Ltd. announced that it has built a production workshop for the adenovirus vector vaccine developed by AstraZeneca and the Oxford. https://t.co/Hip6zcvwhN", "first_save": 1634559108.199414, "hashtags": ["#SHENZHEN", "#DRUGMAKER", "#COVID19", "#VACCINE"]}